Core Laboratories's market cap is currently $837.73M. The company's EPS TTM is $0.669; its P/E ratio is 26.72; and it has a dividend yield of 0.22%. Core Laboratories is scheduled to report earnings on January 29, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 523.85M	$ 509.79M	$ 489.74M	$ 470.25M	$ 487.27M
Gross Profit	$ 88.37M	$ 94.05M	$ 78.92M	$ 83.84M	$ 91.63M
Operating Income	$ 58.56M	$ 54.64M	$ 41.52M	$ 45.26M	$ 55.77M
EBITDA	$ 73.51M	$ 70.42M	$ 58.69M	$ 63.78M	$ -56.50M
Net Income	$ 31.40M	$ 36.67M	$ 19.45M	$ 19.73M	$ -97.07M
Balance Sheet
Cash & Short-Term Investments	$ 19.16M	$ 15.12M	$ 15.43M	$ 17.70M	$ 13.81M
Total Assets	$ 590.41M	$ 586.39M	$ 578.35M	$ 580.85M	$ 568.58M
Total Debt	$ 180.14M	$ 215.38M	$ 222.39M	$ 250.26M	$ 326.98M
Net Debt	$ 160.99M	$ 200.26M	$ 206.96M	$ 232.56M	$ 313.17M
Total Liabilities	$ 332.67M	$ 356.59M	$ 389.40M	$ 419.85M	$ 493.01M
Stockholders' Equity	$ 94.45M	$ 224.81M	$ 188.95M	$ 161.00M	$ 75.57M
Cash Flow
Free Cash Flow	$ 43.36M	$ 14.21M	$ 14.74M	$ 23.04M	$ 45.99M
Operating Cash Flow	$ 56.39M	$ 24.79M	$ 24.96M	$ 36.58M	$ 57.87M
Investing Cash Flow	$ -6.39M	$ -6.65M	$ -3.86M	$ -10.22M	$ 7.85M
Financing Cash Flow	$ -45.96M	$ -18.45M	$ -23.38M	$ -22.46M	$ -63.01M

Currency in USD

Core Laboratories Earnings and Revenue History

Income Statement >

Core Laboratories Debt to Assets

Balance Sheet >

Core Laboratories Cash Flow

Cash Flow >

Core Laboratories Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing